Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis

22Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objectives To determine the role of the B-cell attracting chemokine CXCL-13, which may initiate B-cell trafficking and IgM production in diagnosing HAT meningo-encephalitis. Methods We determined CXCL-13 levels by ELISA on paired sera and CSF of 26 patients from Angola and of 16 controls (six endemic and ten non-endemic). Results were compared to standard stage determination markers and IgM intrathecal synthesis. Results CXCL-13 levels in patients' sera had a median value of 386.6 pg/ml and increased levels were associated with presence of trypanosomes in the CSF but not with other stage markers. CXCL-13 levels in patients' CSF had a median value of 80.9 pg/ml and increased levels were associated with all standard stage determination markers and IgM intrathecal synthesis. Conclusion CXCL-13 levels in CSF increased significantly during the course of HAT. Hence the value of CXCL-13 for diagnosis, follow-up or as a marker of disease severity should be tested in a well-defined cohort study. © 2009 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Courtioux, B., Pervieux, L., Vatunga, G., Marin, B., Josenando, T., Jauberteau-Marchan, M. O., … Bisser, S. (2009). Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis. Tropical Medicine and International Health, 14(5), 529–534. https://doi.org/10.1111/j.1365-3156.2009.02263.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free